Safety and Efficacy of Moringa oleifera Lamarck (1785) — Therapeutic and Toxicological Properties [PDF]
Aires Forte Pinheiro, Jaksilania +9 more
core +2 more sources
Association Between PCSK9 Inhibitor Use and Risk of Age-Related Macular Degeneration. [PDF]
Tsai CY +7 more
europepmc +1 more source
Advanced therapy in familial hypercholesterolemia. [PDF]
Gao E, Brunham LR, Goldman RD.
europepmc +1 more source
Lipid-Lowering Efficacy and Adverse Events of CETP Inhibitor Combination Therapy: A Systematic Review and Network Meta-Analysis. [PDF]
Guo P, Yu X, Wei X, Xiong X, Jiang J.
europepmc +1 more source
Lipid-Lowering Efficacy and Safety of Oral Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-Analysis. [PDF]
Masson W +4 more
europepmc +1 more source
The Efficacy and Safety of Four Novel PCSK9 Monoclonal Antibodies in Patients With Hypercholesterolemia: A Systematic Review With Network Meta-Analysis and Trial Sequential Analysis. [PDF]
Wang S, Li C, Fan D.
europepmc +1 more source
Alirocumab <i>versus</i> Evolocumab on Cardiovascular Outcomes: A Systematic Review and Meta-analysis. [PDF]
Cleto AS +3 more
europepmc +1 more source
Rosuvastatina e ciprofibrato no tratamento da dislipidemia em pacientes com HIV [PDF]
Albert Schiaveto de Souza +5 more
core +1 more source
Sitosterolemia due to compound heterozygous mutations in ABCG5: a case report. [PDF]
Wu LL +7 more
europepmc +1 more source
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and Cancer Risk: Insights from a Large Propensity-Matched Cohort Study. [PDF]
Nardi Agmon I +10 more
europepmc +1 more source

